All In MedTech

Device Trial Radar · NCT04184011

Superficial Radiation Therapy (SRT) for the Treatment of Recurrent Keloid Scars

A Prospective Registry Study to Evaluate the Long-Term Efficacy and Safety of Superficial Radiation Therapy (SRT) for the Treatment of Recurrent Keloid Scars

Last checked: Nov 20, 2026Latest source record: Dec 3, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

100

Planned (sponsor's estimate)

Start

Aug 15, 2019

Primary completion

Aug 16, 2020

Study completion Aug 16, 2020

Sponsor

Lead sponsor
Sensus HealthcareNot on our public-company list
Sponsor type
Industry
First posted
Dec 3, 2019

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Keloid formation in response to skin trauma inflicts about 18 million individuals. A key impediment in successful treatment of keloids is that the predominant treatments, particularly surgical excision and shaving, tend to initiate the regrowth of the keloid at the excision site, and therefore, recurrence rates are high. There is much evidence to demonstrate that following surgical excision procedures with a course of radiation therapy can significantly reduce recurrence rates to as little as 10% or below. This prospective study is to evaluate this claim.

Conditions

  • Keloid Scar

Interventions

  • SRT-100™Device

    SRT delivers a precise, calibrated dose of radiotherapy following surgical excision for large and more difficult-to-treat keloids that cannot otherwise be treated by or have failed more conservative measures.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of keloid recurrence rates.Time frame: 2 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dermatology and Dermatological Surgery

    Boynton Beach, Florida · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.